Chronic Obstructive Pulmonary Disease (COPD) Clinical Trials

Find Chronic Obstructive Pulmonary Disease (COPD) Clinical Trials Near You

The Effect of Airway Oscillation and Chest Wall Oscillation on Respiratory Functions and Sleep Quality in COPD Patients in Acute Exacerbation Period and Technical Inspection of Devices

Status: Recruiting
Location: See location...
Intervention Type: Other, Device
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

Chronic obstructive pulmonary disease (COPD); It is a common, treatable and preventable disease characterized by progressive and irreversible airflow limitation and has systemic effects with respiratory system involvement. Increased respiratory workload, decreased work .

Eligibility
Participation Requirements
Sex: All
Minimum Age: 40
Healthy Volunteers: f
View:

• Being classified as GOLD stage 3 or 4 based on spirometric evaluation in the medical history.

• Having a hospital admission within the specified time frame, evaluated by a pulmonary specialist, and admitted to the pulmonary diseases service with a diagnosis of COPD exacerbation.

• Being 40 years of age or older.

• Voluntarily agreeing to participate in the study.

Locations
Other Locations
Turkey
University of Health Sciences
RECRUITING
Istanbul
Contact Information
Primary
Zuhal KUNDURACILAR, PROF. DR.
zuhal.kunduracilar@sbu.edu.tr
+905302195286
Backup
GAMZE KOYUTÜRK PT, PhD(c)
gamzealtinkaynak@gmail.com
Time Frame
Start Date: 2024-05-01
Estimated Completion Date: 2024-06-17
Participants
Target number of participants: 27
Treatments
Experimental: control
Conventional training was applied to the patients
Experimental: Positive Expiratory Pressure
We applied PEP (positive expiratory pressure) therapy in adddition to the conventional exercises
Experimental: High Frequency Chest Wall Oscillation
We applied HFCWO (High Frequency Chest Wall Oscillation) in addition to the conventional exercises
Sponsors
Leads: Saglik Bilimleri Universitesi
Collaborators: Gulhane Training and Research Hospital

This content was sourced from clinicaltrials.gov